Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$663,305
-$1,013,413 QoQ
Shares Held
17,826
-66.3% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#137
of 252 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. CLDX ranks #161 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in CLDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $663,305 | 17,826 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,676,718 | 52,860 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,702,559 | 136,324 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,657,178 | 257,332 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $13,139,119 | 645,657 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,371,821 | 406,161 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,098,451 | 518,340 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $28,045,726 | 825,117 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $31,294,174 | 845,560 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $24,055,986 | 573,171 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $941,766 | 23,746 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,012,295 | 36,784 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $986,820 | 29,084 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $955,269 | 26,550 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,359,563 | 30,504 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,054,573 | 108,665 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,820,771 | 141,720 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,161,178 | 122,172 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,753,692 | 174,785 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,150,756 | 113,924 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,013,198 | 30,299 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||